JOHN M CAPEK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN M CAPEK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN M CAPEK. JOHN M CAPEK is Executive Vice President in ABBOTT LABORATORIES ($ABT) and President, VI in GUIDANT CORP ($GDT).
Latest Insider Trading Transactions of JOHN M CAPEK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 27.03 | 52,300 | 1,413,857 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 111.86 | 52,300 | 5,850,278 | 316,800 | 369.1 K to 316.8 K (-14.17 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 27.03 | 52,300 | 1,413,857 | 369,100 | 316.8 K to 369.1 K (+16.51 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 27.03 | 52,300 | 1,413,857 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 111.86 | 52,300 | 5,850,278 | 316,800 | 369.1 K to 316.8 K (-14.17 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 27.03 | 52,300 | 1,413,857 | 369,100 | 316.8 K to 369.1 K (+16.51 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 22.39 | 50,100 | 1,121,834 | 0 | |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 96.28 | 18,701 | 1,800,596 | 316,800 | 335.5 K to 316.8 K (-5.57 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 95.63 | 31,399 | 3,002,730 | 335,501 | 366.9 K to 335.5 K (-8.56 %) |
Apr 23 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 22.39 | 50,100 | 1,121,834 | 366,900 | 316.8 K to 366.9 K (+15.81 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 87.72 | 103,446 | 9,074,283 | 103,446 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 16,969 | 0 | 325,504 | 308.5 K to 325.5 K (+5.50 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 26.19 | 46,900 | 1,228,213 | 0 | |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 85.00 | 46,900 | 3,986,500 | 308,535 | 355.4 K to 308.5 K (-13.20 %) |
Jun 21 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 26.19 | 46,900 | 1,228,213 | 355,435 | 308.5 K to 355.4 K (+15.20 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 9,132 | 705,264 | 308,535 | 317.7 K to 308.5 K (-2.87 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 75.90 | 101,519 | 7,705,292 | 101,519 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 19,367 | 0 | 317,667 | 298.3 K to 317.7 K (+6.49 %) |
Jul 26 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 26.02 | 64,900 | 1,688,374 | 0 | |
Jul 26 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Sell | S | 65.00 | 64,900 | 4,218,500 | 298,300 | 363.2 K to 298.3 K (-17.87 %) |
Jul 26 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 26.02 | 64,900 | 1,688,374 | 363,200 | 298.3 K to 363.2 K (+21.76 %) |
Mar 02 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 60.55 | 7,958 | 481,857 | 298,300 | 306.3 K to 298.3 K (-2.60 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 59.94 | 155,495 | 9,320,370 | 155,495 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 28,276 | 0 | 306,258 | 278 K to 306.3 K (+10.17 %) |
Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 45.46 | 10,815 | 491,650 | 277,982 | 288.8 K to 278 K (-3.74 %) |
Nov 18 2016 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | M | 24.38 | 22,000 | 536,386 | 0 | |
Nov 18 2016 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Buy | M | 24.38 | 22,000 | 536,386 | 274,524 | 252.5 K to 274.5 K (+8.71 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 39.52 | 9,980 | 394,410 | 252,524 | 262.5 K to 252.5 K (-3.80 %) |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 38.40 | 214,041 | 8,219,174 | 214,041 | |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 24,414 | 0 | 262,504 | 238.1 K to 262.5 K (+10.25 %) |
Mar 03 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Payment of Exercise | F | 47.61 | 12,312 | 586,174 | 238,090 | 250.4 K to 238.1 K (-4.92 %) |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Option Exercise | A | 47.00 | 165,292 | 7,768,724 | 165,292 | |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | CAPEK JOHN M | Executive Vice Pres ... | Grant | A | 0.00 | 23,457 | 0 | 250,402 | 226.9 K to 250.4 K (+10.34 %) |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Option Exercise | D | 63.11 | 7,500 | 473,325 | 0 | |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Option Exercise | D | 47.41 | 73,534 | 3,486,247 | 0 | |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Option Exercise | D | 51.25 | 50,137 | 2,569,521 | 0 | |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Option Exercise | D | 53.98 | 18,207 | 982,814 | 0 | |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Sell | D | 0.00 | 4,121 | 0 | 0 | 4.1 K to 0 (-100.00 %) |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Sell | D | 0.00 | 116 | 0 | 0 | 116 to 0 (-100.00 %) |
Apr 25 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Sell | D | 0.00 | 9,168 | 0 | 0 | 9.2 K to 0 (-100.00 %) |
Apr 04 2006 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Payment of Exercise | F | 78.03 | 4,328 | 337,714 | 9,168 | 13.5 K to 9.2 K (-32.07 %) |
Jun 03 2005 | GDT | GUIDANT CORP | CAPEK JOHN M | President, VI | Grant | A | 0.00 | 11,500 | 0 | 13,097 | 1.6 K to 13.1 K (+720.10 %) |
Page: 1